Taltz (ixekizumab) - Eli Lilly
Bimzelx (bimekizumab-bkzx) - UCB
Tremfya (guselkumab) - J&J
Cosentyx (secukinumab) - Novartis
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
http://www.ncbi.nlm.nih.gov/pubmed/42084657
 
Christopher T Ritchlin; Désirée van der Heijde; Laura C Coates; Philip J Mease; Proton Rahman
 
May 5, 2026
 
Prev Next